Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01678287 · ClinicalTrials.gov registry record · Phase 1
Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy Adults
A Phase 1 study, sponsored by Astellas Pharma Global Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT01678287 is a Phase 1 study that has completed, run by Astellas Pharma Global Development. The registered enrollment target is 65 participants.
The verdict
NCT01678287, a Phase 1 study, has completed, sponsored by Astellas Pharma Global Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
This is a study of the pharmacokinetic profile and safety and tolerability of ASP1941after repeat dosing and the effect of ASP1941 on glucose levels in non elderly and elderly healthy adult male and female subjects.
Interventions
- DRUG Placebo
- DRUG ASP1941
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01678287
The ClinicalTrials.gov registry entry for NCT01678287 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma Global Development, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01678287 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01678287 about?
NCT01678287 is a clinical study titled "Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy Adults". This is a study of the pharmacokinetic profile and safety and tolerability of ASP1941after repeat dosing and the effect of ASP1941 on glucose levels in non elderly and elderly healthy adult male and female subjects.
What is the current status of trial NCT01678287?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2007-11. Estimated completion is 2008-01.
What interventions are being tested in trial NCT01678287?
The interventions under investigation include: Placebo (DRUG), ASP1941 (DRUG).
Who is sponsoring clinical trial NCT01678287?
This trial is sponsored by Astellas Pharma Global Development, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.